Our research team is heavily involved in investigating outcomes following subarachnoid haemorrhage (SAH) and in developing strategies to improve these outcomes. We coordinate much of this work through the HATCH (Haemoglobin After inTraCranial Haemorrhage) Consortium — an international network of investigators from Europe, the Americas, and Asia. HATCH brings together a diverse range of expertise and resources, united by the goal of improving the lives of patients affected by brain haemorrhage.